38However, although plasma intended for transfusion which is prepared by a method involving an industrial process comes within the material scope of Directive 2001/83, as amended by Directive 2004/27, with respect to its processing, storage and distribution, the product in question, in order to be subject to the provisions of that directive, must none the less also satisfy the conditions laid down in Article 2 of that directive and be able to be regarded as a medicinal product for human use within the meaning of Article 1(2) of Directive 2001/83, as amended by Directive 2004/27.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.